| C026486 | 1,2,5,6-dibenzanthracene | "1,2,5,6-dibenzanthracene results in increased expression of LGALS3 mRNA" | 16269432 |
| C049325 | 1,2-dithiol-3-thione | "1,2-dithiol-3-thione results in decreased expression of LGALS3 mRNA" | 19162173 |
| C548651 | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of LGALS3 mRNA | 19933214 |
| C111118 | 2',3,3',4',5-pentachloro-4-hydroxybiphenyl | "2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of LGALS3 mRNA" | 19114083 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of and affects the localization of LGALS3 protein | 21821001 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | "4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of LGALS3 protein]" | 21821001 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | Cycloheximide inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of LGALS3 protein] | 21821001 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | Dactinomycin inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of LGALS3 protein] | 21821001 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | GSK3B mutant form inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of LGALS3 protein] | 21821001 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | LGALS3 inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased degradation of BCL2L1 protein] | 21821001 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | LGALS3 inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased degradation of MCL1 protein] | 21821001 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | LGALS3 results in decreased susceptibility to 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 21821001 |
| C023514 | 2,6-dinitrotoluene | "2,6-dinitrotoluene results in increased expression of LGALS3 mRNA" | 20406850 |
| C019499 | 2-nitrofluorene | 2-nitrofluorene results in increased expression of LGALS3 mRNA | 15890375 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of LGALS3 mRNA" | 23196670 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl results in increased expression of LGALS3 mRNA" | 20959002 |
| C009505 | 4,4'-diaminodiphenylmethane | "4,4'-diaminodiphenylmethane results in increased expression of LGALS3 mRNA" | 25380136 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA" | 27188386 |
| C494356 | 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione | "4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of LGALS3 protein]" | 21821001 |
| C494356 | 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione | "4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione inhibits the reaction [Cisplatin results in increased expression of LGALS3 protein]" | 21821001 |
| C494356 | 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione | "4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione inhibits the reaction [N-acetylsphingosine results in increased expression of LGALS3 protein]" | 21821001 |
| C018511 | 4-dichlorobenzene | 4-dichlorobenzene results in increased expression of LGALS3 mRNA | 26975756 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of LGALS3 mRNA | 15890375 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA" | 27188386 |
| C020738 | 9,10-dihydro-9,10-dihydroxybenzo(a)pyrene | "9,10-dihydro-9,10-dihydroxybenzo(a)pyrene results in increased expression of LGALS3 mRNA" | 26238291 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of LGALS3 mRNA | 26690555 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of LGALS3 mRNA | 17562736 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of LGALS3 mRNA | 22461450 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of LGALS3 protein | 22461450 |
| D000082 | Acetaminophen | LGALS3 protein affects the reaction [Acetaminophen results in increased expression of CCL20 mRNA] | 22461450 |
| D000082 | Acetaminophen | LGALS3 protein affects the reaction [Acetaminophen results in increased expression of CXCL2 mRNA] | 22461450 |
| D000082 | Acetaminophen | LGALS3 protein affects the reaction [Acetaminophen results in increased expression of LCN2 mRNA] | 22461450 |
| D000082 | Acetaminophen | LGALS3 protein affects the reaction [Acetaminophen results in increased expression of MMP9 mRNA] | 22461450 |
| D000082 | Acetaminophen | LGALS3 protein affects the reaction [Acetaminophen results in increased expression of NOS2 protein] | 22461450 |
| D000082 | Acetaminophen | LGALS3 protein affects the reaction [Acetaminophen results in increased expression of SLC3A2 mRNA] | 22461450 |
| D000082 | Acetaminophen | LGALS3 protein affects the reaction [Acetaminophen results in increased expression of TNFRSF1A mRNA] | 22461450 |
| D000082 | Acetaminophen | LGALS3 protein affects the susceptibility to Acetaminophen | 22461450 |
| D000082 | Acetaminophen | TNFRSF1A protein affects the reaction [Acetaminophen results in increased expression of LGALS3 mRNA] | 22461450 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased expression of LGALS3 mRNA | 27153756 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased expression of LGALS3 mRNA | 19770486 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased expression of LGALS3 mRNA | 15890375 |
| D000517 | alpha-Chlorohydrin | alpha-Chlorohydrin results in decreased expression of LGALS3 mRNA | 28522335 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of LGALS3 mRNA | 16483693 |
| C059765 | amphotericin B, deoxycholate drug combination | "amphotericin B, deoxycholate drug combination results in increased expression of LGALS3 mRNA" | 22863853 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of LGALS3 mRNA | 20458559 |
| D001205 | Ascorbic Acid | Ascorbic Acid results in increased expression of LGALS3 mRNA | 15372504 |
| C006703 | benzo(b)fluoranthene | benzo(b)fluoranthene results in increased expression of LGALS3 mRNA | 16269432 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in increased expression of LGALS3 mRNA | 19737606 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of LGALS3 mRNA | 16269432|2010694 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of LGALS3 protein | 18495319 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of LGALS3 mRNA | 22228805|2373587 |
| D004958 | Estradiol | [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of LGALS3 mRNA | 20823114 |
| D004958 | Estradiol | [Estradiol co-treated with Progesterone] results in decreased expression of LGALS3 mRNA | 20660070 |
| D004958 | Estradiol | Estradiol affects the expression of LGALS3 mRNA | 15598610 |
| D004958 | Estradiol | Estradiol results in increased expression of LGALS3 mRNA | 15289156 |
| C095105 | bexarotene | bexarotene results in decreased expression of LGALS3 mRNA | 16648578 |
| D001629 | Bezafibrate | Bezafibrate results in increased expression of LGALS3 mRNA | 17118139 |
| C542674 | bis((2-oxindol-3-ylimino)-2-(2-aminoethyl)pyridine-N,N')copper(II) | "LGALS3 protein promotes the reaction [bis((2-oxindol-3-ylimino)-2-(2-aminoethyl)pyridine-N,N')copper(II) results in increased abundance of Reactive Oxygen Species]" | 23994248 |
| C542674 | bis((2-oxindol-3-ylimino)-2-(2-aminoethyl)pyridine-N,N')copper(II) | "LGALS3 protein results in increased susceptibility to bis((2-oxindol-3-ylimino)-2-(2-aminoethyl)pyridine-N,N')copper(II)" | 23994248 |
| C543008 | bis(4-hydroxyphenyl)sulfone | bis(4-hydroxyphenyl)sulfone results in decreased expression of LGALS3 mRNA | 25912373 |
| C006780 | bisphenol A | bisphenol A results in increased expression of LGALS3 mRNA | 25181051 |
| C006780 | bisphenol A | bisphenol A results in increased methylation of LGALS3 gene | 28505145 |
| D001761 | Bleomycin | Bleomycin results in increased expression of LGALS3 protein | 26526764 |
| D001761 | Bleomycin | NOS2 protein affects the reaction [Bleomycin results in increased expression of LGALS3 protein] | 26526764 |
| D002065 | Buspirone | Buspirone results in decreased expression of LGALS3 mRNA | 24136188 |
| D002101 | Cacodylic Acid | Cacodylic Acid results in increased expression of LGALS3 mRNA | 16122865 |
| D019256 | Cadmium Chloride | Cadmium Chloride affects the expression of LGALS3 mRNA | 22110744 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of LGALS3 mRNA | 25993096 |
| C059041 | calyculin A | calyculin A results in increased expression of LGALS3 mRNA | 25270620 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride affects the expression of LGALS3 mRNA | 17484886 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of LGALS3 mRNA | 16549783|2379856 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of LGALS3 protein | 16549783 |
| D002251 | Carbon Tetrachloride | LGALS3 gene mutant form inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 mRNA] | 16549783 |
| D002251 | Carbon Tetrachloride | LGALS3 gene mutant form inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] | 16549783 |
| D002251 | Carbon Tetrachloride | MGAT5 protein affects the reaction [Carbon Tetrachloride results in increased expression of LGALS3 mRNA] | 23798564 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride affects the expression of LGALS3 mRNA | 12734012 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride promotes the reaction [PURB protein binds to LGALS3 promoter] | 16309856 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of LGALS3 mRNA | 17522070 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of LGALS3 protein | 12629582|1654978 |
| D002509 | Cephaloridine | Cephaloridine results in increased expression of LGALS3 mRNA | 18500788 |
| D002725 | Chloroform | Chloroform results in increased expression of LGALS3 mRNA | 17522070 |
| D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LGALS3 mRNA | 20938992 |
| C039671 | ciglitazone | [ciglitazone binds to PPARG protein] which results in increased expression of LGALS3 mRNA | 16197558 |
| D002994 | Clofibrate | Clofibrate results in increased expression of LGALS3 mRNA | 17585979 |
| D003033 | Coal Tar | Coal Tar results in increased expression of LGALS3 protein | 18495319 |
| C018021 | cobaltous chloride | cobaltous chloride results in increased expression of LGALS3 mRNA | 24386269 |
| D019327 | Copper Sulfate | Copper Sulfate results in increased expression of LGALS3 mRNA | 19549813 |
| D003471 | Cuprizone | Cuprizone results in increased expression of LGALS3 mRNA | 26577399|2752363 |
| C057862 | cyanoginosin LR | cyanoginosin LR results in increased expression of LGALS3 mRNA | 17654400 |
| D003513 | Cycloheximide | Cycloheximide inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of LGALS3 protein] | 21821001 |
| D016572 | Cyclosporine | Cyclosporine results in increased expression of LGALS3 mRNA | 25562108|2798913 |
| D003609 | Dactinomycin | Dactinomycin inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of LGALS3 protein] | 21821001 |
| C014347 | decitabine | decitabine results in increased expression of LGALS3 mRNA | 19194470 |
| D003907 | Dexamethasone | [GCS-100 co-treated with Dexamethasone] results in decreased expression of LGALS3 protein | 16166312 |
| D003907 | Dexamethasone | Dexamethasone results in decreased expression of LGALS3 mRNA | 17522070 |
| C041517 | dibenzo(a,l)pyrene | "dibenzo(a,l)pyrene results in increased expression of LGALS3 protein" | 18495319 |
| D003994 | Bucladesine | [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of LGALS3 mRNA | 20823114 |
| D002945 | Cisplatin | "4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione inhibits the reaction [Cisplatin results in increased expression of LGALS3 protein]" | 21821001 |
| D002945 | Cisplatin | Cisplatin results in increased expression of LGALS3 mRNA | 27392435 |
| D002945 | Cisplatin | Cisplatin results in increased expression of LGALS3 protein | 21821001 |
| D002945 | Cisplatin | GSK3B mutant form inhibits the reaction [Cisplatin results in increased expression of LGALS3 protein] | 21821001 |
| D002945 | Cisplatin | LGALS3 inhibits the reaction [Cisplatin results in increased degradation of BCL2L1 protein] | 21821001 |
| D002945 | Cisplatin | LGALS3 inhibits the reaction [Cisplatin results in increased degradation of MCL1 protein] | 21821001 |
| D002945 | Cisplatin | LGALS3 protein mutant form results in decreased susceptibility to Cisplatin | 21750908 |
| D002945 | Cisplatin | LGALS3 results in decreased susceptibility to Cisplatin | 21821001 |
| D004008 | Diclofenac | Diclofenac results in increased expression of LGALS3 mRNA | 26934552 |
| C000944 | dicrotophos | dicrotophos results in decreased expression of LGALS3 mRNA | 28302478 |
| D004041 | Dietary Fats | Dietary Fats affects the expression of LGALS3 mRNA | 19680557 |
| D004041 | Dietary Fats | Dietary Fats results in decreased expression of LGALS3 mRNA | 18042831|2501614 |
| D004041 | Dietary Fats | Dietary Fats results in increased expression of LGALS3 mRNA | 22609946 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of LGALS3 mRNA | 24535843 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of LGALS3 mRNA | 28943392 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of LGALS3 mRNA | 19638242 |
| D004054 | Diethylstilbestrol | Diethylstilbestrol results in increased expression of LGALS3 mRNA | 15289156 |
| D004054 | Diethylstilbestrol | Diethylstilbestrol results in increased expression of LGALS3 mRNA | 15890375 |
| D002117 | Calcitriol | Calcitriol results in decreased expression of LGALS3 mRNA | 12875902 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "9,10-Dimethyl-1,2-benzanthracene affects the expression of LGALS3 mRNA" | 21785161 |
| D004128 | Dimethylnitrosamine | Dimethylnitrosamine results in increased expression of LGALS3 mRNA | 17547211 |
| D004128 | Dimethylnitrosamine | Dimethylnitrosamine results in increased expression of LGALS3 mRNA | 15890375|2538013 |
| D004237 | Diuron | Diuron results in increased expression of LGALS3 mRNA | 21551480 |
| D004317 | Doxorubicin | LGALS3 mRNA results in decreased susceptibility to Doxorubicin | 16322897 |
| C118739 | entinostat | entinostat results in increased expression of LGALS3 mRNA | 26272509 |
| C118739 | entinostat | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA" | 27188386 |
| D004918 | Erythromycin Estolate | Erythromycin Estolate results in increased expression of LGALS3 mRNA | 17522070 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of LGALS3 mRNA | 17557909 |
| D005038 | Ethylnitrosourea | Ethylnitrosourea results in increased expression of LGALS3 mRNA | 15954086 |
| D005047 | Etoposide | LGALS3 protein affects the susceptibility to Etoposide | 16217747 |
| C540355 | fenamidone | fenamidone results in increased expression of LGALS3 mRNA | 27029645 |
| D005472 | Fluorouracil | LGALS3 protein affects the susceptibility to Fluorouracil | 16217747 |
| D005472 | Fluorouracil | LGALS3 protein mutant form results in decreased susceptibility to Fluorouracil | 21750908 |
| D005480 | Flurbiprofen | Flurbiprofen results in increased expression of LGALS3 mRNA | 16949054 |
| D005492 | Folic Acid | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LGALS3 mRNA | 20938992 |
| D005492 | Folic Acid | Folic Acid results in increased expression of LGALS3 mRNA | 10980121 |
| C505531 | GCS-100 | [GCS-100 co-treated with Dexamethasone] results in decreased expression of LGALS3 protein | 16166312 |
| D019833 | Genistein | Genistein results in increased expression of LGALS3 mRNA | 15289156 |
| D005897 | Glafenine | Glafenine results in increased expression of LGALS3 mRNA | 24136188 |
| D017313 | Fenretinide | Fenretinide results in decreased expression of LGALS3 mRNA | 28973697 |
| D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of LGALS3 mRNA | 25613284 |
| D007545 | Isoproterenol | Isoproterenol results in increased expression of LGALS3 mRNA | 20003209 |
| C410337 | K 7174 | K 7174 results in increased expression of LGALS3 mRNA | 24086573 |
| D048628 | Ketolides | Ketolides analog results in increased expression of LGALS3 mRNA | 24967691 |
| D007785 | Lactose | Lactose binds to LGALS3 protein | 17385862 |
| C045463 | leflunomide | leflunomide results in increased expression of LGALS3 mRNA | 28988120 |
| C482199 | lipopolysaccharide, E coli O55-B5 | "lipopolysaccharide, E coli O55-B5 results in increased expression of LGALS3 mRNA" | 24972896 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in decreased expression of LGALS3 mRNA | 25613284 |
| D017258 | Medroxyprogesterone Acetate | [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of LGALS3 mRNA | 20823114 |
| D008543 | Melanins | LGALS3 protein results in increased abundance of Melanins | 23994248 |
| C042720 | mercuric bromide | mercuric bromide results in increased expression of LGALS3 mRNA | 26272509 |
| C042720 | mercuric bromide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA" | 27188386 |
| D008701 | Methapyrilene | Methapyrilene results in increased expression of LGALS3 mRNA | 15890375 |
| D008713 | Methimazole | Methimazole results in increased expression of LGALS3 mRNA | 20144635 |
| D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LGALS3 mRNA | 20938992 |
| D008731 | Methoxychlor | Methoxychlor results in increased methylation of LGALS3 gene | 23303685 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of LGALS3 mRNA | 20713471 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in decreased expression of LGALS3 mRNA | 23179753 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of LGALS3 mRNA | 28001369 |
| D008769 | Methylnitronitrosoguanidine | [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of LGALS3 mRNA | 19840844 |
| D008770 | Methylnitrosourea | Methylnitrosourea results in decreased expression of LGALS3 mRNA | 25270620 |
| D015735 | Mifepristone | Mifepristone results in decreased expression of LGALS3 mRNA | 25972201 |
| D016685 | Mitomycin | LGALS3 protein affects the susceptibility to Mitomycin | 16217747 |
| C523799 | MRK 003 | LGALS3 results in increased susceptibility to MRK 003 | 19903844 |
| C064769 | N-acetylsphingosine | "4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione inhibits the reaction [N-acetylsphingosine results in increased expression of LGALS3 protein]" | 21821001 |
| C064769 | N-acetylsphingosine | GSK3B mutant form inhibits the reaction [N-acetylsphingosine results in increased expression of LGALS3 protein] | 21821001 |
| C064769 | N-acetylsphingosine | LGALS3 inhibits the reaction [N-acetylsphingosine results in increased degradation of BCL2L1 protein] | 21821001 |
| C064769 | N-acetylsphingosine | LGALS3 inhibits the reaction [N-acetylsphingosine results in increased degradation of MCL1 protein] | 21821001 |
| C064769 | N-acetylsphingosine | LGALS3 results in decreased susceptibility to N-acetylsphingosine | 21821001 |
| C064769 | N-acetylsphingosine | N-acetylsphingosine results in increased expression of LGALS3 protein | 21821001 |
| D009270 | Naloxone | Naloxone results in increased expression of LGALS3 mRNA | 17522070 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon affects the expression of LGALS3 mRNA" | 23845593 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in increased expression of LGALS3 mRNA" | 25554681 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in increased expression of LGALS3 mRNA" | 25554681|2710602 |
| D015058 | 1-Naphthylisothiocyanate | 1-Naphthylisothiocyanate results in increased expression of LGALS3 mRNA | 17522070|2538013 |
| D009532 | Nickel | Nickel results in increased expression of LGALS3 mRNA | 12540486 |
| C028007 | nickel monoxide | nickel monoxide results in increased expression of LGALS3 mRNA | 19167457 |
| C017557 | nickel subsulfide | nickel subsulfide results in increased expression of LGALS3 mRNA | 21086188 |
| C029938 | nickel sulfate | nickel sulfate results in decreased expression of LGALS3 mRNA | 18651567 |
| C029938 | nickel sulfate | nickel sulfate affects the expression of LGALS3 mRNA | 12718980 |
| C002741 | N-nitrosomorpholine | N-nitrosomorpholine results in increased expression of LGALS3 mRNA | 19716841 |
| C025256 | nonylphenol | nonylphenol results in increased expression of LGALS3 protein | 16054331 |
| C018620 | oleoresins | oleoresins results in decreased expression of LGALS3 mRNA | 20008804 |
| D010098 | Oxycodone | Oxycodone results in decreased expression of LGALS3 mRNA | 23439660 |
| D010100 | Oxygen | Oxygen deficiency results in increased expression of LGALS3 mRNA | 17193925 |
| D010100 | Oxygen | Oxygen results in increased expression of LGALS3 mRNA | 22911455 |
| D010126 | Ozone | Ozone results in increased expression of LGALS3 protein | 22727909 |
| D000073878 | Palm Oil | Palm Oil affects the expression of LGALS3 mRNA | 19680557 |
| D000073878 | Palm Oil | Palm Oil results in decreased expression of LGALS3 mRNA | 18042831 |
| C496932 | panobinostat | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA" | 27188386 |
| C496932 | panobinostat | panobinostat results in increased expression of LGALS3 mRNA | 26272509 |
| C016030 | pantogab | pantogab results in increased expression of LGALS3 mRNA | 17379144 |
| D010269 | Paraquat | Paraquat results in increased expression of LGALS3 protein | 24521700 |
| C086401 | pentabromodiphenyl ether | pentabromodiphenyl ether results in increased expression of LGALS3 mRNA | 26705709 |
| C101814 | perfluoro-n-undecanoic acid | perfluoro-n-undecanoic acid results in decreased expression of LGALS3 mRNA | 23602845 |
| C023036 | perfluorooctanoic acid | perfluorooctanoic acid results in increased expression of LGALS3 protein | 26879310 |
| D010615 | Phenacetin | Phenacetin results in increased expression of LGALS3 mRNA | 17082564|1769850 |
| D010634 | Phenobarbital | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of LGALS3 mRNA | 24535843 |
| D010634 | Phenobarbital | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of LGALS3 mRNA] | 19482888 |
| D010634 | Phenobarbital | Phenobarbital results in increased expression of LGALS3 mRNA | 19482888 |
| D010634 | Phenobarbital | Phenobarbital results in increased expression of LGALS3 mRNA | 19162173 |
| C030299 | phenylhydrazine | phenylhydrazine results in increased expression of LGALS3 mRNA | 17082564|1769850 |
| D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA" | 27188386 |
| D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in increased expression of LGALS3 mRNA | 26272509 |
| D010705 | Phosgene | Phosgene affects the expression of LGALS3 mRNA | 16300373 |
| D010882 | Piperonyl Butoxide | Piperonyl Butoxide results in increased expression of LGALS3 mRNA | 15890375 |
| C006253 | pirinixic acid | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of LGALS3 mRNA | 19710929 |
| C006253 | pirinixic acid | pirinixic acid results in increased expression of LGALS3 mRNA | 17118139 |
| C006253 | pirinixic acid | pirinixic acid results in increased expression of LGALS3 mRNA | 15890375 |
| D010936 | Plant Extracts | Plant Extracts results in decreased expression of LGALS3 protein | 25882088 |
| D011134 | Polysaccharides | Polysaccharides results in decreased expression of LGALS3 protein | 25882088 |
| D011192 | Potassium Dichromate | Potassium Dichromate results in increased expression of LGALS3 protein | 23718831 |
| D011374 | Progesterone | Progesterone affects the expression of LGALS3 mRNA | 23012394 |
| D011374 | Progesterone | [Estradiol co-treated with Progesterone] results in decreased expression of LGALS3 mRNA | 20660070 |
| D011374 | Progesterone | LGALS3 protein affects the metabolism of Progesterone | 17242467 |
| D011374 | Progesterone | Progesterone results in increased expression of LGALS3 mRNA | 19690047 |
| D011441 | Propylthiouracil | Propylthiouracil results in increased expression of LGALS3 mRNA | 24780913 |
| C513428 | pyrachlostrobin | pyrachlostrobin results in increased expression of LGALS3 mRNA | 27029645 |
| D011794 | Quercetin | Quercetin results in increased expression of LGALS3 mRNA | 21632981 |
| C037219 | quinoline | quinoline analog results in increased expression of LGALS3 protein | 18645022 |
| D015125 | Oxyquinoline | Oxyquinoline results in decreased expression of LGALS3 mRNA | 21632981 |
| D017382 | Reactive Oxygen Species | "LGALS3 protein promotes the reaction [bis((2-oxindol-3-ylimino)-2-(2-aminoethyl)pyridine-N,N')copper(II) results in increased abundance of Reactive Oxygen Species]" | 23994248 |
| D017382 | Reactive Oxygen Species | LGALS3 protein results in increased abundance of Reactive Oxygen Species | 23994248 |
| C059514 | resveratrol | [resveratrol co-treated with Streptozocin] results in increased expression of LGALS3 mRNA | 25905778 |
| C059514 | resveratrol | resveratrol results in increased expression of LGALS3 mRNA | 25905778 |
| D012402 | Rotenone | Rotenone results in increased expression of LGALS3 mRNA | 27900601 |
| C541923 | sandostatinLAR | sandostatinLAR results in increased expression of LGALS3 mRNA | 17210224 |
| D012715 | Sesame Oil | Sesame Oil results in decreased expression of LGALS3 mRNA | 29191790 |
| D012822 | Silicon Dioxide | Silicon Dioxide results in increased expression of LGALS3 mRNA | 23221170 |
| D012822 | Silicon Dioxide | Silicon Dioxide results in increased expression of LGALS3 mRNA | 21602193|2243100 |
| C016104 | sodium bichromate | sodium bichromate results in increased expression of LGALS3 mRNA | 25993096 |
| D012969 | Sodium Fluoride | Sodium Fluoride results in decreased expression of LGALS3 protein | 28918527 |
| D053260 | Soot | Soot results in increased expression of LGALS3 mRNA | 22461453 |
| D013311 | Streptozocin | [resveratrol co-treated with Streptozocin] results in increased expression of LGALS3 mRNA | 25905778 |
| D013311 | Streptozocin | Streptozocin results in increased expression of LGALS3 mRNA | 16684804 |
| D013311 | Streptozocin | vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of LGALS3 mRNA] | 16684804 |
| D013467 | Sulindac | Sulindac inhibits the reaction [CDKN1A protein results in increased expression of LGALS3 mRNA] | 15190207 |
| C013698 | tallow | tallow affects the expression of LGALS3 mRNA | 19680557 |
| D013629 | Tamoxifen | Tamoxifen affects the expression of LGALS3 mRNA | 14699072 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of LGALS3 mRNA | 11489354|2010694 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of LGALS3 mRNA | 21570461|2637764 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of LGALS3 mRNA | 20159946 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of LGALS3 mRNA | 17035482|1733744 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of LGALS3 mRNA | 22298810 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of LGALS3 mRNA | 20959002|2121527 |
| D013752 | Tetracycline | Tetracycline results in increased expression of LGALS3 mRNA | 17522070 |
| D013755 | Tetradecanoylphorbol Acetate | [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of LGALS3 mRNA | 19840844 |
| D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of LGALS3 mRNA | 25613284 |
| D013806 | Theophylline | Theophylline results in increased expression of LGALS3 mRNA | 17522070 |
| D013853 | Thioacetamide | MGAT5 protein affects the reaction [Thioacetamide results in increased expression of LGALS3 mRNA] | 23798564 |
| D013853 | Thioacetamide | Thioacetamide results in increased expression of LGALS3 mRNA | 23798564 |
| D013853 | Thioacetamide | [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of LGALS3 mRNA | 28943392 |
| D013864 | Thioglycolates | LGALS3 protein affects the susceptibility to Thioglycolates | 10702423 |
| C009495 | titanium dioxide | titanium dioxide results in increased expression of LGALS3 mRNA | 23409001|2355797 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution affects the expression of LGALS3 mRNA | 20133372 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in decreased expression of LGALS3 mRNA | 28111298 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of LGALS3 mRNA | 12875902 |
| D014212 | Tretinoin | Tretinoin results in increased expression of LGALS3 mRNA | 23724009 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of LGALS3 mRNA | 16604517 |
| D014241 | Trichloroethylene | Trichloroethylene results in increased methylation of LGALS3 gene | 27618143 |
| C012589 | trichostatin A | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA" | 27188386 |
| C012589 | trichostatin A | trichostatin A results in increased expression of LGALS3 mRNA | 24935251|2627250 |
| C016805 | tris(1,3-dichloro-2-propyl)phosphate | "tris(1,3-dichloro-2-propyl)phosphate results in increased expression of LGALS3 mRNA" | 26179874 |
| C013320 | tris(2-butoxyethyl) phosphate | tris(2-butoxyethyl) phosphate affects the expression of LGALS3 mRNA | 29024780 |
| D014415 | Tunicamycin | Tunicamycin results in increased expression of LGALS3 mRNA | 17127020 |
| C406224 | valdecoxib | valdecoxib results in increased expression of LGALS3 mRNA | 24136188 |
| D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA" | 27188386 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of LGALS3 mRNA | 25979313 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of LGALS3 mRNA | 19101580|2317975 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of LGALS3 mRNA | 17963808 |
| C034028 | vanadyl sulfate | vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of LGALS3 mRNA] | 16684804 |
| D014640 | Vancomycin | Vancomycin results in decreased expression of LGALS3 mRNA | 18930951 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in decreased methylation of LGALS3 gene | 25560391 |
| C025643 | vinclozolin | vinclozolin affects the expression of LGALS3 mRNA | 19015723 |
| C025643 | vinclozolin | vinclozolin results in increased expression of LGALS3 mRNA | 23034163 |
| C029297 | vinylidene chloride | vinylidene chloride results in increased expression of LGALS3 mRNA | 26682919 |
| C111237 | vorinostat | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA" | 27188386 |
| C111237 | vorinostat | vorinostat results in increased expression of LGALS3 mRNA | 26272509 |